These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21698518)

  • 1. The distinct role of comparative risk perceptions in a breast cancer prevention program.
    Dillard AJ; Ubel PA; Smith DM; Zikmund-Fisher BJ; Nair V; Derry HA; Zhang A; Pitsch RK; Alford SH; McClure JB; Fagerlin A
    Ann Behav Med; 2011 Oct; 42(2):262-8. PubMed ID: 21698518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer anxiety's associations with responses to a chemoprevention decision aid.
    Dillard AJ; Scherer L; Ubel PA; Smith DM; Zikmund-Fisher BJ; McClure JB; Greene S; Stark A; Fagerlin A
    Soc Sci Med; 2013 Jan; 77():13-9. PubMed ID: 23200299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trait anxiety, symptom perceptions, and illness-related responses among women with breast cancer in remission during a tamoxifen clinical trial.
    Cameron LD; Leventhal H; Love RR
    Health Psychol; 1998 Sep; 17(5):459-69. PubMed ID: 9776005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women's perceptions of breast cancer risk: how you ask matters.
    Woloshin S; Schwartz LM; Black WC; Welch HG
    Med Decis Making; 1999; 19(3):221-9. PubMed ID: 10424829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can risk and illness perceptions predict breast cancer worry in healthy women?
    Gibbons A; Groarke A
    J Health Psychol; 2016 Sep; 21(9):2052-62. PubMed ID: 25712488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.
    Bober SL; Hoke LA; Duda RB; Regan MM; Tung NM
    J Clin Oncol; 2004 Dec; 22(24):4951-7. PubMed ID: 15598980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction.
    Melnikow J; Paterniti D; Azari R; Kuenneth C; Birch S; Kuppermann M; Nuovo J; Keyzer J; Henderson S
    Cancer; 2005 May; 103(10):1996-2005. PubMed ID: 15825209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women's interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aid.
    Fagerlin A; Dillard AJ; Smith DM; Zikmund-Fisher BJ; Pitsch R; McClure JB; Greene S; Alford SH; Nair V; Hayes DF; Wiese C; Ubel PA
    Breast Cancer Res Treat; 2011 Jun; 127(3):681-8. PubMed ID: 21442198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships among breast cancer perceived absolute risk, comparative risk, and worries.
    Lipkus IM; Kuchibhatla M; McBride CM; Bosworth HB; Pollak KI; Siegler IC; Rimer BK
    Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):973-5. PubMed ID: 11008917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge of Potential Harms and Benefits of Tamoxifen among Women Considering Breast Cancer Preventive Therapy.
    Thorneloe RJ; Hall LH; Walter FM; Side L; Lloyd KE; Smith SG;
    Cancer Prev Res (Phila); 2020 Apr; 13(4):411-422. PubMed ID: 31988145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informing women about their breast cancer risks: truth and consequences.
    Lipkus IM; Biradavolu M; Fenn K; Keller P; Rimer BK
    Health Commun; 2001; 13(2):205-26. PubMed ID: 11451105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological and clinical factors implicated in decision making about a trial of low-dose tamoxifen in hormone replacement therapy users.
    Rondanina G; Puntoni M; Severi G; Varricchio C; Zunino A; Feroce I; Bonanni B; Decensi A
    J Clin Oncol; 2008 Mar; 26(9):1537-43. PubMed ID: 18349406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affective forecasting and medication decision making in breast-cancer prevention.
    Hoerger M; Scherer LD; Fagerlin A
    Health Psychol; 2016 Jun; 35(6):594-603. PubMed ID: 26867042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women's decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid.
    Fagerlin A; Zikmund-Fisher BJ; Nair V; Derry HA; McClure JB; Greene S; Stark A; Hensley Alford S; Lantz P; Hayes DF; Wiese C; Claud Zweig S; Pitsch R; Jankovic A; Ubel PA
    Breast Cancer Res Treat; 2010 Feb; 119(3):613-20. PubMed ID: 19908143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute and comparative risk perceptions as predictors of cancer worry: moderating effects of gender and psychological distress.
    Zajac LE; Klein WM; McCaul KD
    J Health Commun; 2006; 11 Suppl 1():37-49. PubMed ID: 16641073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Women's interest in chemoprevention for breast cancer.
    Bastian LA; Lipkus IM; Kuchibhatla MN; Weng HH; Halabi S; Ryan PD; Skinner CS; Rimer BK
    Arch Intern Med; 2001 Jul; 161(13):1639-44. PubMed ID: 11434796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "If I'm better than average, then I'm ok?": Comparative information influences beliefs about risk and benefits.
    Fagerlin A; Zikmund-Fisher BJ; Ubel PA
    Patient Educ Couns; 2007 Dec; 69(1-3):140-4. PubMed ID: 17942271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
    Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
    JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "I'm going to die of something anyway": women's perceptions of tamoxifen for breast cancer risk reduction.
    Paterniti DA; Melnikow J; Nuovo J; Henderson S; DeGregorio M; Kuppermann M; Nease R
    Ethn Dis; 2005; 15(3):365-72. PubMed ID: 16108294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women's perceptions of personalized risk-based breast cancer screening and prevention: An international focus group study.
    Rainey L; Jervaeus A; Donnelly LS; Evans DG; Hammarström M; Hall P; Wengström Y; Broeders MJM; van der Waal D
    Psychooncology; 2019 May; 28(5):1056-1062. PubMed ID: 30848018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.